Showing results (11-20 of 132) with videos related to

Sort By:
Pageof 14
Current Pharmaceutical Design|July 18, 2013
AMPK as a potential anticancer target - friend or foe?Hsiao-Ching Chuang, Chih-Chien Chou, Samuel K Kulp, et al.
Antimicrobial Agents and Chemotherapy|October 1, 2014
Sensitization of intracellular Salmonella enterica serovar Typhimurium to aminoglycosides in vitro and in vivo by a host-targeted antimicrobial agentJung-Hsin Lo, Samuel K Kulp, Ching-Shih Chen, et al.
Journal of Cellular Biochemistry|October 30, 2013
Prospects on strategies for therapeutically targeting oncogenic regulatory factors by small-molecule agentsChih-Chien Chou, Santosh B Salunke, Samuel K Kulp, et al.
The Journal of Biological Chemistry|November 2, 2012
The mRNA-stabilizing factor HuR protein is targeted by β-TrCP protein for degradation in response to glycolysis inhibitionPo-Chen Chu, Hsiao-Ching Chuang, Samuel K Kulp, et al.
Cancer Letters|September 16, 2008
PPARgamma-independent antitumor effects of thiazolidinedionesShuo Wei, Jian Yang, Su-Lin Lee, et al.
Breast Cancer Research and Treatment|June 9, 2012
Differential anti-proliferative activities of poly(ADP-ribose) polymerase (PARP) inhibitors in triple-negative breast cancer cellsHsiao-Ching Chuang, Naval Kapuriya, Samuel K Kulp, et al.
American Journal of Veterinary Research|July 3, 2008
Evaluation of the effects of histone deacetylase inhibitors on cells from canine cancer cell linesWilliam C Kisseberth, Sridhar Murahari, Cheryl A London, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2006
Antitumor effects of a novel phenylbutyrate-based histone deacetylase inhibitor, (S)-HDAC-42, in prostate cancerSamuel K Kulp, Chang-Shi Chen, Da-Sheng Wang, et al.
Pageof 14